The investment seeks to reflect generally the performance of the price of gold. The Trust seeks to reflect such performance before payment of the Trust?s expenses and liabilities. The Trust is not actively managed. It does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of gold. The Shares are intended to constitute a simple and cost-effective means of making an investment similar to an investment in gold. An investment in physical gold requires expensive and sometimes complicated arrangements in connection with the assay, transportation, warehousing and insurance of the metal.
Inception Date: 21/01/2005
Primary Benchmark: LBMA Gold Price PM USD
Primary Index: Morningstar Lng-Only Cmdty TR USD
Gross Expense Ratio: 0.25%
Management Expense Ratio: 0.25 %
|GLD||SPDR Gold Trust||0.40 %||
|SLV||iShares Silver Trust||0.50 %||
|SGOL||ETFS Physical Swiss Gold Share..||0.39 %||
|PSLV||Sprott Physical Silver Trust E..||0.69 %||
|PPLT||ETFS Physical Platinum Shares||0.60 %||
|GLTR||ETFS Physical Precious Metal B..||0.60 %||
|SIVR||ETFS Physical Silver Shares Tr..||0.30 %||
|BAR||GraniteShares Gold Trust Share..||0.00 %||
|OUNZ||VanEck Merk Gold Trust||0.40 %||
|DGL||Invesco DB Gold Fund||0.76 %||
|Market Performance vs.
Industry/Classification (Commodities Precious Metals)
|Market Performance vs. Exchange (NYSE Arca)|
|Value||Sector Median||Percentile Rank||Grade||Market Median||Percentile Rank||Grade|
|Trailing 12 Months|
|Trailing 5 Years|
|Average Annual (5 Year Horizon)|
|Risk Return Profile|
|Volatility (Standard Deviation)||8.81%||74%||C||73%||C|
|Risk Adjusted Return||1.97%||84%||B||20%||F|
|Target Price Action||Rating Action||Analyst||Rating||Price||Date|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock is trading high compared to its peers median on a price to book value basis.
The company had negative total cash flow in the most recent four quarters.
The company had negative total earnings in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.